Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v9-FR | Version v7-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2025-12-09 | 2025-12-08 |
| Drug Identification Number | 02549891 | 02549891 |
| Brand name | CAPVAXIVE | CAPVAXIVE |
| Common or Proper name | Pneumococcal 21-valent conjugate vaccine | Pneumococcal 21-valent conjugate vaccine |
| Company Name | MERCK CANADA INC | MERCK CANADA INC |
| Ingredients | CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 24F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 35B PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 16F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE DEOAC15B PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 31 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23B | CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 24F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 35B PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 16F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE DEOAC15B PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 31 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23B |
| Strength(s) | 65MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG | 65MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG 4MCG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAMUSCULAR | INTRAMUSCULAR |
| Packaging size | 1 DOSE | 1 DOSE |
| ATC code | J07AL | J07AL |
| ATC description | BACTERIAL VACCINES | BACTERIAL VACCINES |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2025-12-12 | 2025-12-12 |
| Actual start date | 2025-12-09 | |
| Estimated end date | 2026-01-05 | 2026-01-05 |
| Actual end date | ||
| Shortage status | Anticipated shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Due to an increased demand for Capvaxive® (Pneumococcal 21-valent conjugate vaccine), the remaining doses will be reserved for the public immunization program. As a result, we will be temporarily closing the private market for this vaccine | Due to an increased demand for Capvaxive® (Pneumococcal 21-valent conjugate vaccine), the remaining doses will be reserved for the public immunization program. As a result, we will be temporarily closing the private market for this vaccine |
| Health Canada comments |